Canada Pension Plan Investment Board Buys Shares of 539,788 Cigna Group $CI

Canada Pension Plan Investment Board bought a new position in shares of Cigna Group (NYSE:CI) during the second quarter, Holdings Channel reports. The institutional investor bought 539,788 shares of the health services provider’s stock, valued at approximately $148,809,000.

A number of other large investors also recently modified their holdings of the business. Evercore Wealth Management LLC raised its stake in Cigna Group by 2.8% during the first quarter. Evercore Wealth Management LLC now owns 1,301 shares of the health services provider’s stock worth $347,000 after acquiring an additional 35 shares during the period. Cary Street Partners Investment Advisory LLC boosted its stake in Cigna Group by 11.0% in the fourth quarter. Cary Street Partners Investment Advisory LLC now owns 363 shares of the health services provider’s stock valued at $100,000 after acquiring an additional 36 shares during the period. IHT Wealth Management LLC grew its holdings in shares of Cigna Group by 2.5% during the fourth quarter. IHT Wealth Management LLC now owns 1,535 shares of the health services provider’s stock valued at $423,000 after purchasing an additional 38 shares during the last quarter. Whetstone Capital Advisors LLC raised its position in shares of Cigna Group by 4.9% during the 4th quarter. Whetstone Capital Advisors LLC now owns 829 shares of the health services provider’s stock worth $228,000 after purchasing an additional 39 shares during the period. Finally, CYBER HORNET ETFs LLC raised its position in shares of Cigna Group by 5.3% during the 4th quarter. CYBER HORNET ETFs LLC now owns 801 shares of the health services provider’s stock worth $220,000 after purchasing an additional 40 shares during the period. 86.99% of the stock is currently owned by institutional investors.

Insider Activity

In other news, insider Nicole S. Jones sold 19,436 shares of the company’s stock in a transaction that occurred on Tuesday, August 4th. The shares were sold at an average price of $276.27, for a total value of $5,369,583.72. Following the completion of the sale, the insider directly owned 27,256 shares of the company’s stock, valued at approximately $7,530,015.12. This represents a 41.63% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the firm’s stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $298.61, for a total transaction of $268,450.39. Following the transaction, the chief accounting officer owned 2,368 shares in the company, valued at $707,108.48. This represents a 27.52% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 23,012 shares of company stock worth $6,386,550. 0.60% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on CI shares. Piper Sandler reduced their price objective on Cigna Group from $370.00 to $346.00 and set an “overweight” rating for the company in a research report on Wednesday, June 3rd. UBS Group increased their target price on Cigna Group from $375.00 to $400.00 and gave the stock a “buy” rating in a research report on Friday, May 22nd. Weiss Ratings reiterated a “hold (c)” rating on shares of Cigna Group in a research note on Monday, June 1st. Jefferies Financial Group downgraded shares of Cigna Group from a “buy” rating to a “hold” rating and reduced their price target for the company from $336.00 to $307.00 in a report on Tuesday, August 4th. Finally, Royal Bank Of Canada upped their price target on shares of Cigna Group from $333.00 to $337.00 and gave the stock an “outperform” rating in a research report on Friday, May 1st. Fifteen equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $339.45.

Cigna Group Stock Up 0.6%

CI opened at $281.01 on Thursday. Cigna Group has a 12 month low of $239.51 and a 12 month high of $315.47. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.76 and a quick ratio of 0.76. The stock has a market cap of $74.25 billion, a P/E ratio of 11.63, a P/E/G ratio of 0.96 and a beta of 0.29. The stock’s 50 day moving average price is $283.58 and its 200 day moving average price is $281.51.

Cigna Group (NYSE:CI) last announced its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.60 by $0.18. The company had revenue of $70.04 billion during the quarter, compared to analyst estimates of $70.14 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.The firm’s quarterly revenue was up 6.7% on a year-over-year basis. During the same quarter in the previous year, the firm posted $7.20 EPS. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, research analysts predict that Cigna Group will post 30.51 earnings per share for the current year.

Cigna Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be given a $1.56 dividend. This represents a $6.24 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date is Tuesday, September 8th. Cigna Group’s dividend payout ratio is currently 25.82%.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.